30% off. Use code SUMMER30 at checkout for 30% off for 12 months on Pro and Premium subscriptions. Subscribe now

Jeff Albers

Track

Insider profile

Currently holds positions in Dianthus Therapeutics Inc and Blueprint Medicines Corp

Performance

Overall performance
2.3
Performance over holding periods
2.3
30 days 90 days 120 days
Average return -6% 8.2% 15.1%
Success rate 27% 68% 82%
Transactions
9 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Dianthus Therapeutics Inc July 1, 2017 -
President, Chief Executive Officer, Director Blueprint Medicines Corp July 1, 2014 -
Jeff Albers's trades of Kymera Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-12-08 2025-12-08
PrS Proposed sale
28,232
251.80
US$1,270,683 		28,232 251.80 US$1,270,683
2025-12-08 2025-12-08
PlS Planned sale
83,793 +19.2%
254.87
US$575,636 		83,793 +19.2% 254.87 US$575,636
2025-12-08 2025-12-08
PlS Planned sale
44,515 +5.5%
411.52
US$3,518,246 		44,515 +5.5% 411.52 US$3,518,246
2025-10-14 2025-10-13
PrS Proposed sale
5,000
57.21
US$286,050 		5,000 57.21 US$286,050
2025-10-14 2025-10-13
PlS Planned sale
5,000 -100.0%
59.19
US$295,949 		5,000 -100.0% 59.19 US$295,949
2025-06-03 2025-06-03
PrS Proposed sale
6,349
43.13
US$273,832 		6,349 43.13 US$273,832
2025-06-03 2025-06-03
PlS Planned sale
6,349 -100.0%
49.00
US$311,101 		6,349 -100.0% 49.00 US$311,101
2025-05-29 2025-05-27
PlS Planned sale
650 -0.4%
101.93
US$66,254 		650 -0.4% 101.93 US$66,254
2025-05-29 2025-05-27
PlS Planned sale
4,350 -2.9%
101.02
US$439,437 		4,350 -2.9% 101.02 US$439,437
2025-05-27 2025-05-27
PrS Proposed sale
5,000
101.14
US$505,686 		5,000 101.14 US$505,686
2025-03-14 2025-03-12
PlS Planned sale
1,800 -1.2%
88.37
US$159,066 		1,800 -1.2% 88.37 US$159,066
2025-03-14 2025-03-12
PlS Planned sale
5,700 -3.6%
87.62
US$499,434 		5,700 -3.6% 87.62 US$499,434
2025-03-17 2025-03-05
S Sale
5,766 -3.8%
88.80
US$512,021 		5,766 -3.8% 88.80 US$512,021
2025-01-23 2025-01-21
PlS Planned sale
200 -0.1%
110.61
US$22,122 		200 -0.1% 110.61 US$22,122
2025-01-23 2025-01-21
PlS Planned sale
7,400 -4.6%
109.92
US$813,408 		7,400 -4.6% 109.92 US$813,408
2025-01-23 2025-01-21
PlS Planned sale
7,561 -4.5%
109.11
US$824,981 		7,561 -4.5% 109.11 US$824,981
2025-01-21 2025-01-21
PrS Proposed sale
10,000
109.39
US$1,093,929 		10,000 109.39 US$1,093,929
2025-01-21 2025-01-21
PrS Proposed sale
5,161
109.79
US$566,627 		5,161 109.79 US$566,627
2025-01-15 2025-01-13
PlS Planned sale
5,000 -3.1%
102.28
US$511,400 		5,000 -3.1% 102.28 US$511,400
2025-01-14 2025-01-13
PrS Proposed sale
5,000
102.28
US$511,398 		5,000 102.28 US$511,398
2024-12-20 2024-12-19
PlS Planned sale
2,100 -1.3%
91.96
US$193,116 		2,100 -1.3% 91.96 US$193,116
2024-12-20 2024-12-19
PlS Planned sale
3,800 -2.3%
91.15
US$346,370 		3,800 -2.3% 91.15 US$346,370
2024-12-20 2024-12-19
PlS Planned sale
5,180 -3.1%
89.01
US$461,072 		5,180 -3.1% 89.01 US$461,072
2024-12-20 2024-12-19
PlS Planned sale
3,920 -2.3%
88.28
US$346,058 		3,920 -2.3% 88.28 US$346,058
2024-12-19 2024-12-19
PrS Proposed sale
15,000
89.78
US$1,346,633 		15,000 89.78 US$1,346,633
2024-11-12 2024-11-07
PrS Proposed sale
5,000
102.00
US$510,000 		5,000 102.00 US$510,000
2024-11-12 2024-11-07
PlS Planned sale
5,000 -3.1%
102.00
US$510,000 		5,000 -3.1% 102.00 US$510,000
2024-11-07 2024-11-07
PrS Proposed sale
5,000
102.00
US$510,000 		5,000 102.00 US$510,000
2024-11-08 2024-11-06
PlS Planned sale
6,700 -19.7%
36.76
US$246,313 		6,700 -19.7% 36.76 US$246,313
2024-10-28 2024-10-25
PlS Planned sale
300 -0.9%
36.43
US$10,929 		300 -0.9% 36.43 US$10,929
2024-10-25 2024-10-25
PrS Proposed sale
7,000
33.70
US$235,900 		7,000 33.70 US$235,900
2024-09-11 2024-09-09
PlS Planned sale
7,734 -4.7%
85.12
US$658,318 		7,734 -4.7% 85.12 US$658,318
2024-09-11 2024-09-09
PlS Planned sale
11,968 -6.8%
85.86
US$1,027,572 		11,968 -6.8% 85.86 US$1,027,572
2024-09-09 2024-09-09
PrS Proposed sale
19,702
85.57
US$1,685,911 		19,702 85.57 US$1,685,911
2024-08-26 2024-08-26
PrS Proposed sale
5,000
47.78
US$238,900 		5,000 47.78 US$238,900
2024-08-26 2024-08-26
PlS Planned sale
5,000 -100.0%
49.10
US$245,508 		5,000 -100.0% 49.10 US$245,508
2024-03-22 2024-03-20
PlS Planned sale
1,367 -0.8%
89.12
US$121,827 		1,367 -0.8% 89.12 US$121,827
2024-03-22 2024-03-20
PlS Planned sale
6,285 -3.4%
88.60
US$556,851 		6,285 -3.4% 88.60 US$556,851
2024-03-22 2024-03-20
PlS Planned sale
8,440 -4.4%
87.26
US$736,474 		8,440 -4.4% 87.26 US$736,474
2024-03-22 2024-03-20
PlS Planned sale
6,251 -3.2%
86.46
US$540,461 		6,251 -3.2% 86.46 US$540,461
2024-03-22 2024-03-20
PlS Planned sale
2,730 -1.4%
85.22
US$232,651 		2,730 -1.4% 85.22 US$232,651
2024-03-26 2024-03-07
S Sale
11,033 -6.3%
90.69
US$1,000,583 		11,033 -6.3% 90.69 US$1,000,583
2024-02-21 2024-02-21
PrS Proposed sale
4,385
38.03
US$166,762 		4,385 38.03 US$166,762
2024-02-21 2024-02-21
PlS Planned sale
4,385 -100.0%
39.05
US$171,227 		4,385 -100.0% 39.05 US$171,227
2024-02-21 2024-02-20
PlS Planned sale
615 -100.0%
39.07
US$24,031 		615 -100.0% 39.07 US$24,031